Belhadj Soumaya, Rentsch Andreas, Schwede Frank, Paquet-Durand François
Cell Death Mechanism Group, Institute for Ophthalmic Research, Eberhard-Karls-Universität Tübingen, Tübingen, Germany.
Biolog Life Science Institute GmbH & Co. KG, Bremen, Germany.
PLoS One. 2021 Jan 22;16(1):e0245369. doi: 10.1371/journal.pone.0245369. eCollection 2021.
Poly-ADP-ribose-polymerase (PARP) relates to a family of enzymes that can detect DNA breaks and initiate DNA repair. While this activity is generally seen as promoting cell survival, PARP enzymes are also known to be involved in cell death in numerous pathologies, including in inherited retinal degeneration. This ambiguous role of PARP makes it attractive to have a simple and fast enzyme activity assay, that allows resolving its enzymatic activity in situ, in individual cells, within complex tissues. A previously published two-step PARP activity assay uses biotinylated NAD+ and streptavidin labelling for this purpose. Here, we used the fluorescent NAD+ analogues ε-NAD+ and 6-Fluo-10-NAD+ to assess PARP activity directly on unfixed tissue sections obtained from wild-type and retinal degeneration-1 (rd1) mutant retina. In standard UV microscopy ε-NAD+ incubation did not reveal PARP specific signal. In contrast, 6-Fluo-10-NAD+ resulted in reliable detection of in situ PARP activity in rd1 retina, especially in the degenerating photoreceptor cells. When the 6-Fluo-10-NAD+ based PARP activity assay was performed in the presence of the PARP specific inhibitor olaparib, the activity signal was completely abolished, attesting to the specificity of the assay. The incubation of live organotypic retinal explant cultures with 6-Fluo-10-NAD+, did not produce PARP specific signal, indicating that the fluorescent marker may not be sufficiently membrane-permeable to label living cells. In summary, we present a new, rapid, and simple to use fluorescence assay for the cellular resolution of PARP activity on unfixed tissue, for instance in complex neuronal tissues such as the retina.
聚(ADP - 核糖)聚合酶(PARP)属于一类能够检测DNA断裂并启动DNA修复的酶家族。虽然这种活性通常被认为有助于细胞存活,但PARP酶在许多病理状况下,包括遗传性视网膜变性中,也被认为与细胞死亡有关。PARP的这种模糊作用使得拥有一种简单快速的酶活性检测方法很有吸引力,该方法能够在复杂组织中的单个细胞内原位解析其酶活性。此前发表的一种两步PARP活性检测方法为此使用了生物素化的NAD⁺和链霉亲和素标记。在这里,我们使用荧光NAD⁺类似物ε - NAD⁺和6 - Fluo - 10 - NAD⁺,直接在从野生型和视网膜变性1(rd1)突变体视网膜获得的未固定组织切片上评估PARP活性。在标准紫外显微镜下,ε - NAD⁺孵育未显示PARP特异性信号。相比之下,6 - Fluo - 10 - NAD⁺能够可靠地检测rd1视网膜中的原位PARP活性,尤其是在退化的光感受器细胞中。当在PARP特异性抑制剂奥拉帕尼存在的情况下进行基于6 - Fluo - 10 - NAD⁺的PARP活性检测时,活性信号完全消失,证明了该检测方法的特异性。用6 - Fluo - 10 - NAD⁺孵育活的视网膜器官型外植体培养物,未产生PARP特异性信号,表明荧光标记物可能没有足够的膜通透性来标记活细胞。总之,我们提出了一种新的、快速且易于使用的荧光检测方法,用于在未固定组织上以细胞分辨率解析PARP活性,例如在视网膜等复杂神经元组织中。